Ignite Creation Date:
2024-05-06 @ 9:49 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03087448
Status:
TERMINATED
Last Update Posted:
2022-12-27
First Post:
2017-02-10
Brief Title:
Ceritinib Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer NSCLC
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco